186 related articles for article (PubMed ID: 2269381)
61. Hemolytic uremic syndrome in a patient with systemic sclerosis treated with cyclosporin A.
Zachariae H; Hansen HE; Olsen TS
Acta Derm Venereol; 1992 Aug; 72(4):307-9. PubMed ID: 1357898
[TBL] [Abstract][Full Text] [Related]
62. Efficacy of cyclosporin A in systemic sclerosis.
Gisslinger H; Burghuber OC; Stacher G; Schwarz W; Punzengruber C; Graninger W; Luger TA; Wolff K; Smolen JS
Clin Exp Rheumatol; 1991; 9(4):383-90. PubMed ID: 1934687
[TBL] [Abstract][Full Text] [Related]
63. Treatment of severe localized scleroderma by plasmapheresis--report of three cases.
Wach F; Ullrich H; Schmitz G; Landthaler M; Hein R
Br J Dermatol; 1995 Oct; 133(4):605-9. PubMed ID: 7577592
[TBL] [Abstract][Full Text] [Related]
64. [A case of overlap syndrome of PSS, SLE and Sjögren syndrome treated by cyclosporin A: an improvement of sclerosis of the skin].
Kume A; Ueda K; Sano S; Funai T; Kobayashi Y; Hashimoto K; Yoshikawa K
Nihon Hifuka Gakkai Zasshi; 1989 Oct; 99(11):1191-6. PubMed ID: 2614988
[TBL] [Abstract][Full Text] [Related]
65. [Piascledine in the treatment of scleroderma].
Szczepański A; Dabrowska H; Moskalewska K
Przegl Dermatol; 1974; 61(4):525-7. PubMed ID: 4849404
[No Abstract] [Full Text] [Related]
66. Bullous lesions in scleroderma.
Rencic A; Goyal S; Mofid M; Wigley F; Nousari HC
Int J Dermatol; 2002 Jun; 41(6):335-9. PubMed ID: 12100687
[TBL] [Abstract][Full Text] [Related]
67. [Antinuclear antibodies in mesenchymal scleroderma and progressive systemic sclerosis (author's transl)].
Sugiura M; Hashimoto T; Kurihara S; Nishikawa T; Hatano H
Nihon Hifuka Gakkai Zasshi; 1980 Sep; 90(10):935-7. PubMed ID: 7012401
[No Abstract] [Full Text] [Related]
68. The use of pentoxifylline in the treatment of systemic sclerosis and lipodermatosclerosis: a unifying hypothesis?
Goldman MP
J Am Acad Dermatol; 1994 Jul; 31(1):135-6. PubMed ID: 8054069
[No Abstract] [Full Text] [Related]
69. Ultrastructure of cutaneous cellular infiltrates in scleroderma.
Fleischmajer R; Perlish JS; West WP
Arch Dermatol; 1977 Dec; 113(12):1661-6. PubMed ID: 202203
[TBL] [Abstract][Full Text] [Related]
70. Induction of Scleroderma Fibrosis in Skin-Humanized Mice by Administration of Anti-Platelet-Derived Growth Factor Receptor Agonistic Autoantibodies.
Luchetti MM; Moroncini G; Jose Escamez M; Svegliati Baroni S; Spadoni T; Grieco A; Paolini C; Funaro A; Avvedimento EV; Larcher F; Del Rio M; Gabrielli A
Arthritis Rheumatol; 2016 Sep; 68(9):2263-73. PubMed ID: 27111463
[TBL] [Abstract][Full Text] [Related]
71. Circulating Fc gamma receptor-specific autoantibodies in localized and systemic scleroderma.
Davis K; Boros P; Keltz M; Unkeless JC; Fleischmajer R
J Am Acad Dermatol; 1995 Oct; 33(4):612-6. PubMed ID: 7673494
[TBL] [Abstract][Full Text] [Related]
72. Salazopyrin (azulfidine) treatment in scleroderma.
Dover N
Isr J Med Sci; 1971 Nov; 7(11):1301-3. PubMed ID: 4400695
[No Abstract] [Full Text] [Related]
73. [Use of Tebessal in scleroderma].
Mattos O; de Oliveira Neto MP
Rev Bras Med; 1972 Mar; 29(3):139-40. PubMed ID: 5033154
[No Abstract] [Full Text] [Related]
74. Dimethyl sulfoxide in the treatment of scleroderma.
Engel MF
South Med J; 1972 Jan; 65(1):71-3. PubMed ID: 5058095
[No Abstract] [Full Text] [Related]
75. [Therapeutic action of coagulation factor XIII in scleroderma. 20 cases].
Thivolet J; Perrot H; Meunier F; Bouchet B
Nouv Presse Med; 1975 Nov; 4(39):2779-82. PubMed ID: 1105424
[TBL] [Abstract][Full Text] [Related]
76. [Treatment of scleroderma with depolymerizing agents].
Konopík J; Krs V
Cas Lek Cesk; 1982 Nov; 121(44):1368-72. PubMed ID: 7172189
[No Abstract] [Full Text] [Related]
77. [Effect of piascledine treatment of scleroderma].
Szczepański A; Dabrowska H; Moskalewska K
Przegl Dermatol; 1975; 62(4):555-8. PubMed ID: 1162105
[No Abstract] [Full Text] [Related]
78. [Immunogenetic studies of familial occurrence of progressive systemic scleroderma and circumscribed scleroderma].
Holzmann H; Schlieter A; Altmeyer P; Kühnl P
Hautarzt; 1992 Sep; 43(9):548-53. PubMed ID: 1399599
[TBL] [Abstract][Full Text] [Related]
79. Scleroderma in children.
Zulian F
Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):576-595. PubMed ID: 29773274
[TBL] [Abstract][Full Text] [Related]
80. Increased levels of circulating intercellular adhesion molecule-1 in patients with localized scleroderma.
Ihn H; Fujimoto M; Sato S; Kikuchi K; Igarashi A; Soma Y; Takehara K
J Am Acad Dermatol; 1994 Oct; 31(4):591-5. PubMed ID: 7916356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
